Correction: A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.

Authors

Breelyn A Wilky, Katherine A Julian, Alessandra Maleddu, Anne C Mailhot, Chelsey R Cartwright, Dexiang Gao, Cristiam Moreno Tellez, Lindsey E Kemp, Nicholas R Therrien, Sumra S Chaudhry, Jeffrey D Rytlewski, Qierra R Brockman, Eduardo Davila, Anthony D Elias

Published in

Clinical cancer research : an official journal of the American Association for Cancer Research. Volume 32. Issue 14. Pages 3102. Jul 17, 2026.

PMID:
42464639
Bibliographic data and abstract were imported from PubMed on 17 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.